Article info

Download PDFPDF

Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al

Authors

  1. Correspondence to Dr Christoph T Berger, Biomedicine, University Hospital Basel, Basel 4031, Switzerland; Christoph.Berger{at}usb.ch
View Full Text

Citation

Berger CT, Daikeler T
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson et al

Publication history

  • Received May 20, 2019
  • Accepted May 21, 2019
  • First published May 29, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.